775
Views
27
CrossRef citations to date
0
Altmetric
Research Article

The impact of race, ethnicity, age and sex on clinical outcome in chronic lymphocytic leukemia: a comprehensive Surveillance, Epidemiology, and End Results analysis in the modern era

, , , , , & show all
Pages 2778-2784 | Received 16 Sep 2013, Accepted 23 Feb 2014, Published online: 03 Apr 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Paulina Stefaniuk, Julia Onyszczuk, Agnieszka Szymczyk & Monika Podhorecka. (2021) Therapeutic Options for Patients with TP53 Deficient Chronic Lymphocytic Leukemia: Narrative Review. Cancer Management and Research 13, pages 1459-1476.
Read now
Laura S. Samples & Solomon A. Graf. (2018) On the front line: first choice pharmacotherapeutics for chronic lymphocytic leukemia. Expert Opinion on Pharmacotherapy 19:15, pages 1675-1684.
Read now
Yazan Migdady, Mohammed Salhab, Nam H. Dang, Merry J. Markham & Adam J. Olszewski. (2016) Disparities in conditional net survival among non-Hodgkin lymphoma survivors: a population-based analysis. Leukemia & Lymphoma 57:3, pages 676-684.
Read now
Lukáš Smolej. (2015) Targeted treatment for chronic lymphocytic leukemia: clinical potential of obinutuzumab. Pharmacogenomics and Personalized Medicine 8, pages 1-7.
Read now

Articles from other publishers (23)

Adam S. Kittai, Ying Huang, Seema A. Bhat, Electra D. Paskett, Kerry A. Rogers, Jacqueline C. Barrientos, James L. Fisher & Jennifer A. Woyach. (2023) Racial and socioeconomic disparities in CLL/SLL: analysis of SEER data from 2006 to 2019. Blood Advances 7:11, pages 2575-2579.
Crossref
Joanna M. Rhodes, Jacqueline C. Barrientos & Kanti R. Rai. (2022) How Have Targeted Agents Changed the Treatment Landscape for Elderly Patients with CLL?. Current Oncology Reports.
Crossref
David E. Spaner. (2021) O-GlcNAcylation in Chronic Lymphocytic Leukemia and Other Blood Cancers. Frontiers in Immunology 12.
Crossref
Alfonso E. Bencomo-Alvarez, Andres J. Rubio, Mayra A. Gonzalez & Anna M. Eiring. (2021) Blood cancer health disparities in the United States Hispanic population. Molecular Case Studies 7:2, pages a005967.
Crossref
K. Vanura. (2021) Sex as decisive variable in lymphoid neoplasms—an update. ESMO Open 6:1, pages 100001.
Crossref
Alicia Villavicencio, Marta Solans, Lluís Zacarías-Pons, Anna Vidal, Montse Puigdemont, Josep Maria Roncero, Marc Saez & Rafael Marcos-Gragera. (2021) Comorbidities at Diagnosis, Survival, and Cause of Death in Patients with Chronic Lymphocytic Leukemia: A Population-Based Study. International Journal of Environmental Research and Public Health 18:2, pages 701.
Crossref
IntisarShakir Ali, GhassanAhmed Al-Ani, YaseenM Taher & AlaaFadhil Alwan. (2020) Prognostic values of β2 microglobulin, interleukin-4, and interleukin-6 in patients with different stages of chronic lymphocytic leukemia. Iraqi Journal of Hematology 9:1, pages 47.
Crossref
Ovie Utuama, Fahad Mukhtar, Yen Thi-Hai Pham, Bashir Dabo, Priyashi Manani, Jenna Moser, Abimbola Michael-Asalu, Chi TD Tran, Linh C. Le, Thanh V. Le, Khanh Truong Vu, Jong Y. Park, Paolo Boffetta, Wei Zheng, Xiao-Ou Shu & Hung N. Luu. (2019) Racial/ethnic, age and sex disparities in leukemia survival among adults in the United States during 1973-2014 period. PLOS ONE 14:8, pages e0220864.
Crossref
Nathalie Jacque & Véronique Leblond. (2019) La leucémie lymphoïde chronique : mise au point. La Presse Médicale 48:7-8, pages 807-815.
Crossref
Paolo Strati, Nitin Jain & Susan O'Brien. (2018) Chronic Lymphocytic Leukemia: Diagnosis and Treatment. Mayo Clinic Proceedings 93:5, pages 651-664.
Crossref
John G. Gribben, Francesc Bosch, Florence Cymbalista, Christian H. Geisler, Paolo Ghia, Peter Hillmen, Carol Moreno & Stephan Stilgenbauer. (2018) Optimising outcomes for patients with chronic lymphocytic leukaemia on ibrutinib therapy: European recommendations for clinical practice. British Journal of Haematology 180:5, pages 666-679.
Crossref
Ahmad Salimi & Jalal Pourahmad. 2018. Polyphenols: Prevention and Treatment of Human Disease. Polyphenols: Prevention and Treatment of Human Disease 195 203 .
Chadi Nabhan, Anthony Mato, Christopher R. Flowers, David L. Grinblatt, Nicole Lamanna, Mark A. Weiss, Matthew S. Davids, Arlene S. Swern, Shriya Bhushan, Kristen Sullivan, E. Dawn Flick, Pavel Kiselev & Jeff P. Sharman. (2017) Characterizing and prognosticating chronic lymphocytic leukemia in the elderly: prospective evaluation on 455 patients treated in the United States. BMC Cancer 17:1.
Crossref
Teresa Amato, Abibatou Sall, Tandakha NDiaye Dièye, Alessandro Gozzetti, Michele Iacono, Maria Raffaella Ambrosio, Massimo Granai, Serena Somma, Saliou Diop, Awa Oumar Touré, Evelyne May, Charles Henry Gattiollat, Joëlle Wiels, Yonis Ahmed, Martine Raphael, Lorenzo Leoncini, Cristiana Bellan & Pier Paolo Piccaluga. (2017) Preferential Usage of Specific Immunoglobulin Heavy Chain Variable Region Genes With Unmutated Profile and Advanced Stage at Presentation Are Common Features in Patients With Chronic Lymphocytic Leukemia From Senegal. American Journal of Clinical Pathology 148:6, pages 545-554.
Crossref
Paolo Strati, Sameer A. Parikh, Kari G. Chaffee, Neil E. Kay, Timothy G. Call, Sara J. Achenbach, James R. Cerhan, Susan L. Slager & Tait D. Shanafelt. (2017) Relationship between co-morbidities at diagnosis, survival and ultimate cause of death in patients with chronic lymphocytic leukaemia (CLL): a prospective cohort study. British Journal of Haematology 178:3, pages 394-402.
Crossref
Alexandra Walsh, Joseph Chewning, Xuelin Li, Chen Dai, Kimberly Whelan, Avi Madan-Swain, John Waterbor, Monica L. Baskin & Frederick D. Goldman. (2017) Inferior outcomes for black children with high risk acute lymphoblastic leukemia and the impact of socioeconomic variables. Pediatric Blood & Cancer 64:2, pages 267-274.
Crossref
Thomas J. Kipps, Freda K. Stevenson, Catherine J. Wu, Carlo M. Croce, Graham Packham, William G. Wierda, Susan O'Brien, John Gribben & Kanti Rai. (2017) Chronic lymphocytic leukaemia. Nature Reviews Disease Primers 3:1.
Crossref
EmineKilic Bagir, Arbil Acikalin, Perihan Alsancak, Semra Paydas, Emel Gurkan & Melek Ergin. (2017) Prevalence of cytogenetic abnormalities in chronic lymphocytic leukemia in the southern part of Turkey. Indian Journal of Cancer 54:3, pages 572.
Crossref
Chadi Nabhan, Kari G. Chaffee, Susan L. Slager, Natalie Galanina, Sara J. Achenbach, Susan M. Schwager, Neil E. Kay & Tait D. Shanafelt. (2016) Analysis of racial variations in disease characteristics, treatment patterns, and outcomes of patients with chronic lymphocytic leukemia. American Journal of Hematology 91:7, pages 677-680.
Crossref
Tom Fleischer, Tung-Ti Chang, Jen-Huai Chiang, Ching-Yun Hsieh, Mao-Feng Sun & Hung-Rong Yen. (2016) Integration of Chinese Herbal Medicine Therapy Improves Survival of Patients With Chronic Lymphocytic Leukemia. Medicine 95:21, pages e3788.
Crossref
Jennifer A. Crozier, Taimur Sher, Dongyun Yang, Abhisek Swaika, James Foran, Radhika Ghosh, Han Tun, Gerardo Colon-Otero, Kevin Kelly, Asher Chanan-Khan & Sikander Ailawadhi. (2015) Persistent Disparities Among Patients With T-Cell Non-Hodgkin Lymphomas and B-Cell Diffuse Large Cell Lymphomas Over 40 Years: A SEER Database Review. Clinical Lymphoma Myeloma and Leukemia 15:10, pages 578-585.
Crossref
Jorge J. Castillo, Adam J. Olszewski, Sandra Kanan, Kirsten Meid, Zachary R. Hunter & Steven P. Treon. (2015) Overall survival and competing risks of death in patients with Waldenström macroglobulinaemia: an analysis of the Surveillance, Epidemiology and End Results database. British Journal of Haematology 169:1, pages 81-89.
Crossref
Jorge J. Castillo, Irene M. Ghobrial & Steven P. Treon. 2015. Non-Hodgkin Lymphoma. Non-Hodgkin Lymphoma 177 195 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.